U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: February 6-12, 2022
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: February 6-12, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 02/11/2022
Location: Virtual
Subject: Enteric Viruses in Berries
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, and other invited guests

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 02/10/2022
Location: Virtual
Subject: Safe Food Coalition Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several executives from across the consumer associations, and scientific and technical staff from industry

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 02/08/2022
Location: Virtual
Subject: Member State Mechanism on Substandard and Falsified Medical Products Informal Markets Working Group Meeting
FDA Participant/Group: LEAH HSU-LUFTMAN
Non FDA Participant/Group: Representatives of member states for the Mechanism on Substandard and Falsified Medical Products working group

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 02/07/2022
Location: Virtual
Subject: Pharmaceutical Researchers and Manufacturers of America (PhRMA) Meeting
FDA Participant/Group: THERESA MULLIN; MICHAEL KOPCHA; PETER STEIN; JACQUELINE CORRIGAN CURAY;
Non FDA Participant/Group: Representatives from Pharmaceutical Researchers and Manufacturers of America

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 02/07/2022
Location: Virtual
Subject: World Health Organization (WHO) Informal Consultation on Considerations for Regulatory Convergence of Cell and Gene Therapy Products (CGTP); Global Access to CGTPs
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 02/10/2022
Location: Virtual
Subject: COVID-19 Vaccine Education and Equity Project; Speaker: Addressing Ongoing COVID-19 Vaccine Questions with CDC and FDA Experts
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 02/09/2022
Location: Virtual
Subject: General Medical Device Updates
FDA Participant/Group: BRENDAN O'LEARY; MICHELLE TARVER; SONJA FULMER; BAKUL PATEL; SUZANNE SCHWARTZ; CATHERINE BAHR; COURTNEY LIAS; MALVINA EYDELMAN; ANGELA KRUEGER; BRADLEY CUNNINGHAM; JESSICA PAULSEN; WILLIAM MAISEL;
Non FDA Participant/Group: David Amor, Divya Nag, Sam Surette, Sumbul Ahmad Desai (Apple);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top